Intellectual Property Position

miRagen Therapeutics is the owner or exclusive licensee of close to 20 patents covering cardiovascular and skeletal muscle miRNAs as well as chemistries for therapeutic oligonucleotide technologies. With established intellectual property, miRagen is confident of its leadership position in miRNA research and development for the treatment of cardiovascular and muscle disease.